Overview

Simvastatin as a Treatment for Pulmonary Hypertension

Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to investigate the safety and efficacy of adding simvastatin to the current conventional treatment regimen for the management of pulmonary hypertension.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Imperial College London
Collaborator:
Medical Research Council
Treatments:
Simvastatin